Convergence of HIV, TB, Drug Use, Hepatitis. Transforming the HIV/TB Response: Defining the next 10 years

Size: px
Start display at page:

Download "Convergence of HIV, TB, Drug Use, Hepatitis. Transforming the HIV/TB Response: Defining the next 10 years"

Transcription

1 Convergence of HIV, TB, Drug Use, Hepatitis Transforming the HIV/TB Response: Defining the next 10 years

2 Estimated numbers of IDUs and regional prevalence of HIV in people who inject drugs, 2010 Beyrer, et al. Time to act: a call for comprehensive responses to HIV in people who use drugs. Lancet, July 2010

3 Opium production in Afghanistan Modified from data from the UNODC World Drug Reports Copyright, The Lancet

4 Prevalence of IDU among MSM Prevalence of IDU among MSM in Southern Africa Malawi (n=18) Namibia (n=16) Botswana (n=4) South Africa (n=5) Pooled Country Baral, S. et al. HIV Prevalence, Risks for HIV Infection, and Human Rights among men who have sex with men (MSM) in Malawi, Namibia, and Botswana. PLoS One

5 HIV Prevalence 80.00% HIV Prevalence among SSA FSW Beyrer, et al, Lancet ID % 60.00% 50.00% 40.00% 30.00% SW Prevalence HIV Prevalence Women % 10.00% 0.00%

6 Aceijas and Rhodes Int J Drug Policy 2007 HCV follows IDU epidemics Injection drug use reported in 151 countries Estimated 15.9 million IDUs Evidence of HCV in 57 countries where IDU reported All report estimates >20% Reference Group to the United Nations on HIV and Injecting Drug Use 2010

7 In most settings, the prevalence is much higher HCV positive HCV negative Baltimore, US Ottowa/Quebec, CA Vancouver, CA Manipur,India St Petersburg, Russia Thomas DL Medicine 1995; Solomon SS Ind J Med Res 2011; Devi Ind J Med Microbiol 2004; Patrick DM Can Med Assoc J 2001; Roy E Int J STD AIDS 2007; Paintsil Addiction 2009

8 Most HIV-infected IDUs are co-infected with HCV HCV coinfected HIV only Men who have sex with men Heterosexual Injection drug users 0% 20% 40% 60% 80% 100% Rockstroh JID 2005; Sulkowski Ann Intern Med 2003;

9 Most HIV-infected IDUs are co-infected with HCV (ASIA) HCV coinfected HIV only Chennai NE India Vietnam Taiwan 0% 20% 40% 60% 80% 100% Solomon SS JAIDS 2008; Mahanta AIDS Care 2009; Quan VM AIDS Care 2009; Liang HS J Microbiol Immunol Infect 2008

10 TB Incidence HIV Prevalence in TB Cases 10 WHO, Global TB Control 2011

11 Percent of TB Patients Tested for HIV: 2004 and (%) 2010 (%) Global AFRO AMRO Brazil South Africa Zambia

12 Combination prevention and treatment approaches for people who use drugs

13 Photo: Hans Jürgen Burkard

14 Effect of ART on HIV incidence after 5 years for different eligibility criteria and yearly recruitment rates Degenhardt, et al. Prevention of HIV infection for people who inject drugs. Lancet 2010.

15 Scaling up Combination HIV Interventions when force of infection is great: Nairobi. (Strathdee, et al, Lancet 2010) Must optimize efficacy AND coverage of needle exchange programs and opioid substitution tx to have impact

16 New HIV-1 diagnoses in France, Le Vu et al. Population-based HIV-1 incidence in France, : a modelling analysis. Lancet ID, Oct 2010.

17 Photo: Hans Jürgen Burkard

18 IDU as share of total HIV cases and of patients receiving ART, 2008 Wolfe, et al. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet July 2010.

19 IDUs receiving government-funded methadone or buprenorphine treatment, 2009 Wolfe, et al. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet

20 Photo: Hans Jürgen Burkard

21 Number of IDUs receiving government-funded methadone or buprenorphine treatment versus those in drug detention, 2009 Wolfe, et al. Lancet July2010.

22 Detention is not Treatment: A voice from China I was addicted to heroin for several years before being sent to into an involuntary treatment centre in my country. Since the day I was sent, I was never given any medicine As soon as I was considered detoxified, the warden hurriedly arranged for me to labour at a locked factory. I worked 16 hours a day, overstretched, and if I failed to complete my workload, I would be treated with violent beatings It is dubbed rehabilitation through labour but I never felt that I was rehabilitating; the only thing I felt was punishment, and I believe everyone else there felt the same. --Li Wei

23 Photo: Dan Bigg

24 Bottom Lines Drug use and drug policies are driving emerging HIV, hepatitis, TB epidemics in too many settings Combination approaches to prevention and treatment for drug users can save lives and can control disease spread Incarceration is not treatment, detention is not treatment, and both increase disease risks and vulnerabilities

25 Acknowledgements Lancet Co-authors Steffanie Strathdee Louisa Degenhardt Brad Mathers Daniel Wolfe Johns Hopkins David Dowdy Andrea Wirtz Shruti Mehta Deanna Kerrigan Stef Baral

HIV/AIDS and Human Rights: Conflicts and Synergies

HIV/AIDS and Human Rights: Conflicts and Synergies HIV/AIDS and Human Rights: Conflicts and Synergies Chris Beyrer MD, MPH The Center for Public Health and Human Rights Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Overview

More information

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.

More information

HARM REDUCTION IN ASIA. Adeeba Kamarulzaman University of Malaya, Kuala Lumpur

HARM REDUCTION IN ASIA. Adeeba Kamarulzaman University of Malaya, Kuala Lumpur HARM REDUCTION IN ASIA Adeeba Kamarulzaman University of Malaya, Kuala Lumpur Prevalence of HIV among IDUs: 2007 DU identified in 148 countries 15.9 million PWID No estimate of HIV prevalence 0%

More information

Injecting Drug Users: A Global Problem. Roger Detels, M.D., M.S.

Injecting Drug Users: A Global Problem. Roger Detels, M.D., M.S. Injecting Drug Users: A Global Problem Roger Detels, M.D., M.S. Global Areas of Drug User- Europe Transmitted HIV North America (U.S., Canada) South America Southeast Asia (Thailand, Myanmar, Vietnam,

More information

Prevention and Treatment of HIV/AIDS among Drug Using Populations: NIDA s Research Priorities

Prevention and Treatment of HIV/AIDS among Drug Using Populations: NIDA s Research Priorities Prevention and Treatment of HIV/AIDS among Drug Using Populations: NIDA s Research Priorities Jacques Normand, Ph.D. Director, AIDS Research Program NIDA/NIH Objectives Briefly Characterize the magnitude

More information

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014

More information

Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries

Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries Petersen et al. Harm Reduction Journal 2013, 10:13 RESEARCH Open Access Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries Zaino Petersen 1*,

More information

Government of Canada Federal AIDS Initiative Milestones

Government of Canada Federal AIDS Initiative Milestones HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for

More information

China Country Advocacy Brief Injecting Drug Use and HIV

China Country Advocacy Brief Injecting Drug Use and HIV United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS for Asia and the Pacific China Country Advocacy Brief Injecting Drug Use and HIV Key actions to be supported Expansion of the national

More information

Projected Demand for HIV Diagnostic Tests

Projected Demand for HIV Diagnostic Tests Projected Demand for HIV Diagnostic Tests John Stover, Yu Teng, Adebiyi Adesina, Eline Korenromp On behalf of the Diagnostics Forecasting Technical Working Group (CDC, CHAI, GFATM, PfSCM, UNAIDS, UNICEF,

More information

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC The Comprehensive Package: The simple truth about our response to drug related HIV Dr. Monica Beg, Signe Rotberga UNODC HIV among injecting drug users Why is it so important? 30% global HIV infections

More information

HIV and Harm Reduction in Prisons

HIV and Harm Reduction in Prisons HIV and Harm Reduction in Prisons School of Public Health and Community Medicine Professor Kate Dolan Program of International Research and Training National Drug and Alcohol Research Centre UNSW, Sydney,

More information

HIV in Russia. Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy

HIV in Russia. Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy HIV in Russia Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy Elisa F. Long, M.S. Margaret L. Brandeau, Ph.D. Tatyana Vinichenko, M.D., M.P.A. Cristina M. Galvin, M.S. Swati

More information

Integration of collaborative TB/HIV activities with harm reduction services

Integration of collaborative TB/HIV activities with harm reduction services Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases control, Head of Department on HIV/AIDS combating

More information

Opioid Withdrawal, Opioid Substitution, and HIV Infection

Opioid Withdrawal, Opioid Substitution, and HIV Infection Opioid Withdrawal, Opioid Substitution, and HIV Infection R. Douglas Bruce, MD, MA, MS Associate Clinical Professor of Medicine Yale University New Haven, Connecticut Learning Objectives After attending

More information

HIV, drugs and the legal environment

HIV, drugs and the legal environment HIV, drugs and the legal environment Steffanie A. Strathdee (University of California San Diego, La Jolla, CA, USA), Leo Beletsky (Northeastern University School of Law and Bouvé College of Health Sciences,

More information

Opioid Withdrawal, Opioid Substitution, and HIV Infection

Opioid Withdrawal, Opioid Substitution, and HIV Infection Opioid Withdrawal, Opioid Substitution, and HIV Infection R. Douglas Bruce, MD, MA, MS Associate Clinical Professor of Medicine Yale University New Haven, Connecticut Learning Objectives After attending

More information

Trends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University

Trends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University Trends in HIV/AIDS epidemic in Asia, and its challenge Taro Yamamoto Institute of Tropical Medicine Nagasaki University Millennium Development Goals Goal 1. Eradicate extreme poverty and hunger Goal 2.

More information

Epidemiology and economics: modelling the scenarios for the end of AIDS

Epidemiology and economics: modelling the scenarios for the end of AIDS Epidemiology and economics: modelling the scenarios for the end of AIDS Controlling the HIV Epidemic with Antiretrovirals: from consensus to implementations London, England September 22, 2013 Reuben Granich,

More information

4th Asian Academic Society International Conference (AASIC) 2016 HEA-OR-095

4th Asian Academic Society International Conference (AASIC) 2016 HEA-OR-095 HEA-OR-095 SITUATION ANALYSIS ON HIV PREVALENCE AMONG PWID IN VIETNAM Hoa Nguyen Institute Population and Social Research, Mahidol University, Thailand Corresponding author s email: nguyentunamkhanhhoa@gmail.com

More information

Place of addiction-informed comprehensive treatment in HIV care

Place of addiction-informed comprehensive treatment in HIV care Place of addiction-informed comprehensive treatment in HIV care Cecile Denis, PhD Center for Studies of Addiction, University of Pennsylvania, Philadelphia, USA University of Bordeaux, Bordeaux, France

More information

INH Prophylaxis Therapy (IPT) should NOT be implemented for all HIV patients in the Asia Pacific

INH Prophylaxis Therapy (IPT) should NOT be implemented for all HIV patients in the Asia Pacific INH Prophylaxis Therapy (IPT) should NOT be implemented for all HIV patients in the Asia Pacific Thuy Le, MD DPhil Duke University School of Medicine, USA Oxford University Clinical Research Unit Hospital

More information

PrEP May Cause a Revolution in HIV Prevention: Time to Get Ready

PrEP May Cause a Revolution in HIV Prevention: Time to Get Ready PrEP May Cause a Revolution in HIV Prevention: Time to Get Ready Thomas J. Coates PhD Michael and Sue Steinberg Professor of Global AIDS Research David Geffen School of Medicine University of California,

More information

Technical Guidance Note for Global Fund HIV Proposals

Technical Guidance Note for Global Fund HIV Proposals Technical Guidance Note for Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including this activity in the proposal The World Health Organization (WHO), the Joint United

More information

Syringe type and HIV risk: current knowledge and future directions

Syringe type and HIV risk: current knowledge and future directions Syringe type and HIV risk: current knowledge and future directions Presented by William A. Zule, Dr.PH Along with Georgiy V. Bobashev, Curtis M. Coomes, Don C. Des Jarlais, Samuel R. Friedman, V. Anna

More information

This document was generated by the Reference Group to the United Nations on HIV and Injecting Drug Use.

This document was generated by the Reference Group to the United Nations on HIV and Injecting Drug Use. This document was generated by the Group to the United Nations on HIV and Injecting Drug Use. The data included in this report reflect the results of a systematic search and review of data on a range of

More information

WOMEN & HIV: A GLOBAL UPDATE. Deanna Kerrigan, PhD, MPH Associate Professor Health, Behavior & Society

WOMEN & HIV: A GLOBAL UPDATE. Deanna Kerrigan, PhD, MPH Associate Professor Health, Behavior & Society WOMEN & HIV: A GLOBAL UPDATE Deanna Kerrigan, PhD, MPH Associate Professor Health, Behavior & Society Objectives Review the current global burden of HIV among women Trends and progress to date Groups with

More information

HIV AND PEOPLE WHO INJECT DRUGS

HIV AND PEOPLE WHO INJECT DRUGS UNAIDS 2017 HIV AND PEOPLE WHO INJECT DRUGS People who use and inject drugs are among the groups at highest risk of exposure to HIV, but remain marginalized and out of reach of health and social services.

More information

AIDS by the Numbers: Where Do We Stand with ? Peter Ghys, UNAIDS

AIDS by the Numbers: Where Do We Stand with ? Peter Ghys, UNAIDS AIDS by the Numbers: Where Do We Stand with 90-90-90? Peter Ghys, UNAIDS ACHIEVING THE 90 90 90 TARGETS, 2016 FIGURE 3.2. COUNTRIES THAT HAVE ACHIEVED THE 90 90 90 TARGETS OR ARE NEAR TO ACHIEVING THEM,

More information

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009 The role of UNODC in working law enforcement agencies to promote harm reduction IHRC, Bangkok, 23 April 2009 Drug control has focused mostly on law enforcement Public health which is the first principle

More information

Treatment of Hepatitis C in People Who Inject Drugs (PWIDs) Andrew Seaman, MD OHA P&T Meeting January, 2017

Treatment of Hepatitis C in People Who Inject Drugs (PWIDs) Andrew Seaman, MD OHA P&T Meeting January, 2017 Treatment of Hepatitis C in People Who Inject Drugs (PWIDs) Andrew Seaman, MD OHA P&T Meeting January, 2017 Conflicts of interest Receive

More information

Why Are We Concerned About Adolescents Particularly Adolescent Girls and Young Women and HIV?

Why Are We Concerned About Adolescents Particularly Adolescent Girls and Young Women and HIV? Why Are We Concerned About Adolescents Particularly Adolescent Girls and Young Women and HIV? Epidemiology of HIV in Adolescent & Young Women Lynne M. Mofenson MD Elizabeth Glaser Pediatric AIDS Foundation

More information

CENTRE FOR RESEARCH EXCELLENCE INTO INJECTING DRUG USE (CREIDU)

CENTRE FOR RESEARCH EXCELLENCE INTO INJECTING DRUG USE (CREIDU) CENTRE FOR RESEARCH EXCELLENCE INTO INJECTING DRUG USE (CREIDU) SUBMISSION TO UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON THE WORLD DRUG PROBLEM NOVEMBER 2015 This submission was written by CREIDU

More information

Injecting Drug Use and the Harm Reduction Model_Merritt_HPP-507. This paper explores the role that law enforcement and police actions can play as

Injecting Drug Use and the Harm Reduction Model_Merritt_HPP-507. This paper explores the role that law enforcement and police actions can play as This paper explores the role that law enforcement and police actions can play as structural deterrents to the conceptualization of drug addiction as a public health issue rather than as a criminal justice

More information

OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success

OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success XVIII International AIDS Conference, 2010 Vienna UNODC-GTZ Satellite Symposium: OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success Joerg

More information

What works: prevention for drug injectors. Holly Hagan Don C. Des Jarlais. Corina Lelutiu-Weinberger

What works: prevention for drug injectors. Holly Hagan Don C. Des Jarlais. Corina Lelutiu-Weinberger What works: A synthesis of research on HCV prevention for drug injectors Holly Hagan Don C. Des Jarlais Enrique R. Pouget Corina Lelutiu-Weinberger Center for Drug Use and HIV Research NDRI New York, NY

More information

Tracking the HIV/AIDS epidemic in

Tracking the HIV/AIDS epidemic in 7 th IAS Conference on HIV Pathogenesis, Treatment and Prevention Tracking the HIV/AIDS epidemic in Asia and the Pacific Mr. J.V.R. Prasada Rao UN Secretary General Special Envoy on HIV/AIDS in Asia Pacific

More information

Epidemiology of non medical use of prescription drugs. Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch

Epidemiology of non medical use of prescription drugs. Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch Epidemiology of non medical use of prescription drugs Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch Monitoring of the drug use situation: Annual reports questionnaire

More information

Harm Reduction in Nigeria

Harm Reduction in Nigeria Harm Reduction in Nigeria Needs, gaps, and responses to ensure access to effective HIV prevention, treatment and care for people who inject drugs February 2018 This document is made possible by the generous

More information

HIV Drug Resistance Regional Update Eastern & Southern African Region

HIV Drug Resistance Regional Update Eastern & Southern African Region HIV Drug Resistance Regional Update Eastern & Southern African Region Dr R Banda, IST/ESA Dr F Cham, IST/ESA Dr RG Vaz, WHO AFRO HIVDR Steering Committee Meeting, Geneva 11-12 November 2009 1 Presentation

More information

Civil Society Driven Response in Ukraine: A program making a difference and bringing results

Civil Society Driven Response in Ukraine: A program making a difference and bringing results Civil Society Driven Response in Ukraine: A program making a difference and bringing results CATIE Forum Making it work: From Planning to Practice October 16th, 2015 Andriy Klepikov International HIV/AIDS

More information

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness

More information

Using Data For Decision Making

Using Data For Decision Making Using Data For Decision Making Juliana Víctor-Ahuchogu World Bank Acknowledgment and data sources AIDS in the Commonwealth of Independent States: AIDS 2008 MAP Report: Magomed Nashkhoev & Boris Sergeyev,

More information

STI and HIV Prevention and Care among Sex Workers

STI and HIV Prevention and Care among Sex Workers Training Course in Sexual and Reproductive Health Research 2017 Module: Sexually transmitted infections, HIV/AIDS STI and HIV Prevention and Care among Sex Workers Annette Verster and Michelle Rodolph

More information

Opioid Withdrawal, Opioid Substitution Treatment, and HIV Infection

Opioid Withdrawal, Opioid Substitution Treatment, and HIV Infection Opioid Withdrawal, Opioid Substitution Treatment, and HIV Infection R. Douglas Bruce, MD, MA, MS Associate Clinical Professor of Medicine Yale University Chief of Medicine Cornell Scott-Hill Health Center

More information

Progress in scaling up HIV prevention and treatment in sub-saharan Africa: 15 years, the state of AIDS

Progress in scaling up HIV prevention and treatment in sub-saharan Africa: 15 years, the state of AIDS 10 th International Workshop on HIV treatment, Pathogenesis and Prevention Research in Resource-Limited setting (INTEREST, 3-6 May, 2016) Progress in scaling up HIV prevention and treatment in sub-saharan

More information

Hepatitis B Epidemiology and Prevention in the Elimination Era John W. Ward, MD

Hepatitis B Epidemiology and Prevention in the Elimination Era John W. Ward, MD Hepatitis B Epidemiology and Prevention in the Elimination Era John W. Ward, MD Director, Program for Viral Hepatitis Elimination, Task Force for Global Health Senior Scientist, National Center for HIV/AIDS,

More information

Combination prevention: Public health and human rights imperatives

Combination prevention: Public health and human rights imperatives Combination prevention: Public health and human rights imperatives Gottfried Hirnschall, MD MPH HIV/AIDS Department WHO, Geneva London, June 11, 2012 Outline The epidemic and response What is combination

More information

5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives

5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives Persistent Challenge of HIV Transmission Control in Injection Drug Use: The Indiana Outbreak John T. Brooks, MD Senior Medical Advisor, Division of HIV/AIDS Prevention National Center for HIV/AIDS, Viral

More information

Effects of combination approach on harm reduction programs: the Taiwan experience

Effects of combination approach on harm reduction programs: the Taiwan experience Lin et al. Harm Reduction Journal (2016) 13:23 DOI 10.1186/s12954-016-0112-3 RESEARCH Open Access Effects of combination approach on harm reduction programs: the Taiwan experience Ting Lin 1,2, Chang-Hsun

More information

Ending the AIDS epidemic by 2030

Ending the AIDS epidemic by 2030 Ending the AIDS epidemic by 2030 Steven J. Kraus Director UNAIDS Regional Support Team, Asia and the Pacific for the UNAIDS Regional Management Meeting 25 th October 2014 Number Regional overview of trends

More information

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres Objectives The Epidemiology of HIV/AIDS in the EECA Region (Trends) o The Burden of HIV/AIDS

More information

National Conference of State Legislators

National Conference of State Legislators National Conference of State Legislators Mark W. Parrino, M.P.A. Monday, July 20, 2009 Philadelphia, PA Medication Assisted Treatment for Opiate Addiction In the Criminal Justice System Updated August

More information

Collaborative TB and HIV Services for People Who Use Drugs

Collaborative TB and HIV Services for People Who Use Drugs Collaborative TB and HIV Services for People Who Use Drugs From Mekong to Bali: The Scale up of TB/HIV collaborative activities in Asia Pacific Bali, Indonesia, 8-9 August 2009 Fabio Mesquita, MD, PhD

More information

Past, present & future for HIV self-testing

Past, present & future for HIV self-testing Past, present & future for HIV self-testing Cheryl Johnson WHO HIV Dept. Geneva 19 July 2014 No conflict of interest Why talk about HIVST? UNAIDS 90-90-90 10% 5% 49% 90% 95% 51% Current coverage 2020 Goal

More information

Blood-borne viruses in marginalised populations

Blood-borne viruses in marginalised populations Blood-borne viruses in marginalised populations 2 May 2014 SYDNEY MEDICAL SCHOOL Bethany White, PhD Discipline of Addiction Medicine Overview Blood-borne viruses: HIV Hepatitis B virus (HBV) Hepatitis

More information

Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies

Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies Wendee Wechsberg, PhD, Senior Director Substance Abuse Treatment Evaluations and Interventions

More information

Update on roll out of PrEP

Update on roll out of PrEP Update on roll out of PrEP Dr Rachel Baggaley, Michelle Rodolph, Dr Shona Dalal, Dr Ioannis Hodges-Mameletzis WHO HIV Department Geneva, Switzerland Regulatory pathways and clinical trial design for long-acting

More information

511,000 (57% new cases) ~50,000 ~30,000

511,000 (57% new cases) ~50,000 ~30,000 Latest global TB estimates - 2007 (Updated Mar 2009) All forms of TB Greatest number of cases in Asia; greatest rates per capita in Africa Multidrug-resistant TB (MDR-TB) Estimated number of cases 9.27

More information

India Country Advocacy Brief Injecting Drug Use and HIV

India Country Advocacy Brief Injecting Drug Use and HIV United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS for Asia and the Pacific India Country Advocacy Brief Injecting Drug Use and HIV Key actions to be supported Formulation of legislation

More information

Cambodia Country Advocacy Brief Injecting Drug Use and HIV

Cambodia Country Advocacy Brief Injecting Drug Use and HIV United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS for Asia and the Pacific Situation of drug use and HIV Cambodia Country Advocacy Brief Injecting Drug Use and HIV Key actions to be

More information

Needle exchange programs

Needle exchange programs Needle exchange programs What science tells us about needle exchange programs Kerstin Käll, MD, PhD University of Linköping, Sweden Klas Rönnbäck, Ulrich Hermansson, Sten Rönnberg HIV and Injecting Drug

More information

KAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA

KAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA KAZAKHSTAN Territory : 2,717,300 km 2 Capital: Astana Map No. 3771 Rev. 6 UNITED NATIONS January 2004 BASIC DATA Total population (millions) 2009 15.5* Population under age15 (as % of total) 2010 23.8*

More information

CROI 2017 Review: Hepatitis C Coinfection

CROI 2017 Review: Hepatitis C Coinfection Mountain West AIDS Education and Training Center CROI 2017 Review: Hepatitis C Coinfection Brian R. Wood, MD Assistant Professor of Medicine Medical Director, Mountain West AETC ECHO Telehealth February

More information

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach Ines Perea Ministry of Health, Germany Reasons for a new strategy in 2016 New international agreements (SDG s) Renewed political

More information

Strategic use of antiretroviral drugs to prevent HIV transmission

Strategic use of antiretroviral drugs to prevent HIV transmission Strategic use of antiretroviral drugs to prevent HIV transmission 22th Tunisian Congress of Infectious Diseases 2nd Congress of Federation of Arab Societies of Clinical Microbiology and Infectious Diseases

More information

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and

More information

HIV Prevention Strategies HIV Pre-exposure prophylaxis

HIV Prevention Strategies HIV Pre-exposure prophylaxis HIV Prevention Strategies HIV Pre-exposure prophylaxis Michael Martin, MD, MPH Director HIV Research Program Thailand MOPH U.S. CDC Collaboration The findings and conclusions in this presentation are those

More information

Facts & Figures. HIV Estimates

Facts & Figures. HIV Estimates Facts & Figures HIV Estimates - 2003 Globally, the HIV sentinel surveillance system has been recognised as an optimal mechanism to monitor trends of HIV infection in specific high-risk groups as well as

More information

Limiting the spread of hepatitis C virus with Treatment as Prevention (TasP)

Limiting the spread of hepatitis C virus with Treatment as Prevention (TasP) From TreatmentUpdate 197 Limiting the spread of hepatitis C virus with Treatment as Prevention (TasP) The idea of Treatment as Prevention, or TasP, has been proposed and is being implemented in some regions

More information

Sex Work in Sub-Saharan Africa : Opportunities and Challenges

Sex Work in Sub-Saharan Africa : Opportunities and Challenges Sex Work in Sub-Saharan Africa : Opportunities and Challenges Dr Traore Isidore May 26, 2016 Definition of Sex Worker Female, male and transgender adults (18 years of age and above) who receive money or

More information

Drug Use, Prisons and Compulsory Drug Treatment Centers

Drug Use, Prisons and Compulsory Drug Treatment Centers Drug Use, Prisons and Compulsory Drug Treatment Centers Sonia Bezziccheri, UNODC Regional Centre for East Asia and the Pacific Thai Satellite Meeting 19 April, 2009 Background In Thailand, drug offences

More information

Epidemiology. The Global HIV Epidemic Among MSM and Key Populations: Time to Act 12/2/2013. HIV incidence among MSM,

Epidemiology. The Global HIV Epidemic Among MSM and Key Populations: Time to Act 12/2/2013. HIV incidence among MSM, Key Messages What makes Key Populations Key? The Global HIV Epidemic Among MSM and Key Populations: Time to Act ANAC 2013, Atlanta Chris Beyrer MD, MPH Johns Hopkins Bloomberg School of Public Health Key

More information

Reflections on the use of future HIV vaccines as part of an integrated package of preventive measures

Reflections on the use of future HIV vaccines as part of an integrated package of preventive measures Reflections on the use of future HIV vaccines as part of an integrated package of preventive measures Walter Jaoko, KAVI Institute of Clinical Research, University of Nairobi 2016 Global Vaccine & Immunization

More information

South Asian Cocktail The Predominant Drug Use Pattern in Nepal and its Association with Spread of HIV

South Asian Cocktail The Predominant Drug Use Pattern in Nepal and its Association with Spread of HIV 14 Original Article South Asian Cocktail The Predominant Drug Use Pattern in Nepal and its Association with Spread of HIV Ojha S P 1, Sigdel S 2, H-G M 3, Verthein U 4 1 Tribhuvan University Teaching Hospital,

More information

Asia is large and diverse. HIV/AIDS: Regional and Thailand. The Asian HIV Epidemic. Praphan Phanuphak, M.D., Ph.D.

Asia is large and diverse. HIV/AIDS: Regional and Thailand. The Asian HIV Epidemic. Praphan Phanuphak, M.D., Ph.D. Asia is large and diverse HIV/AIDS: Regional and Thailand Scenario Praphan Phanuphak, M.D., Ph.D. The Thai Red Cross AIDS Research Centre ASAP-sponsored SBW: ICAAP-11; Nov. 21, 2013 A continent with largest

More information

Dr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia

Dr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia Dr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia Growing evidence in changing of usage, from natural plant substances to synthetic substances

More information

Scaling up priority HIV/AIDS interventions in the health sector

Scaling up priority HIV/AIDS interventions in the health sector TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June

More information

Understanding Key Populations: Removing Legal Barriers to Prisons Health and Human Rights. Nthabiseng Mokoena

Understanding Key Populations: Removing Legal Barriers to Prisons Health and Human Rights. Nthabiseng Mokoena Understanding Key Populations: Removing Legal Barriers to Prisons Health and Human Rights. Nthabiseng Mokoena Key Populations The World health Organisation (WHO) defines key populations as groups who,

More information

Modelling and Simulation in Public Health

Modelling and Simulation in Public Health Modelling and Simulation in Public Health Margaret Brandeau Department of Management Science and Engineering Stanford University My talk today Need for analysis Four modeling/simulation studies Disease

More information

Key populations and HIV

Key populations and HIV Key populations and HIV Annette Verster & Virginia Macdonald Training Course in Sexual and Reproductive Health Research Geneva 2017 Median HIV prevalence (%) in key populations vs general population by

More information

Supporting the Establishment of Prison- based Harm Reduction Policies and Programs in Eastern Europe and the Former Soviet Union

Supporting the Establishment of Prison- based Harm Reduction Policies and Programs in Eastern Europe and the Former Soviet Union Supporting the Establishment of Prison- based Harm Reduction Policies and Programs in Eastern Europe and the Former Soviet Union Thomas Kerr 1, Matt Curtis 2, Ralf Jürgens 1 1 Canadian HIV/AIDS Legal Network

More information

26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1

26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1 The 16 th Core Group Meeting of the TB/HIV Working Group 26 28 May 2010, Almaty, Kazkhstan Nina Kerimi UNODC Regional Project Coordinator 1 UNODC Regional Office for Central Asia covers 6 countries: AZE,

More information

)./0)N156)N ''' "&.' 5;)2,7N-5+)2, ''' '." 5;)2,7N-5+)2,

)./0)N156)N ''' &.' 5;)2,7N-5+)2, ''' '. 5;)2,7N-5+)2, 018/)1,5 =n@,alalofmanj En 5oKJD )IE=! 191 192 018/)1,5 =n@,alalofmanj En 5oKJD )IE=! +oknjho.=?j5daaji )./0)N156)N 2oFKl=JEonmEllEonI.%% 5;)2,7N-5+)2*, )nnk=lfofkl=jeonchomjd.% 5;)2,7N-5+)2, 2oFKl=JEon@AnIEJOFAHIG.km

More information

Getting to zero HIV new infections in Asia and the Pacific region: Possible or impossible dream?

Getting to zero HIV new infections in Asia and the Pacific region: Possible or impossible dream? Getting to zero HIV new infections in Asia and the Pacific region: Possible or impossible dream? Steven J. Kraus Director UNAIDS Regional Support Team, Asia and the Pacific Timothy D. Mastro Director,

More information

KNOWING YOUR RESPONSE MSM AND THEIR NEEDS IN LOW- AND MIDDLE-INCOME COUNTRIES

KNOWING YOUR RESPONSE MSM AND THEIR NEEDS IN LOW- AND MIDDLE-INCOME COUNTRIES KNOW YOUR EPIDEMIC AND KNOWING YOUR RESPONSE MSM AND THEIR NEEDS IN LOW- AND MIDDLE-INCOME COUNTRIES Stefan Baral MD MPH CCFP FRCPC Johns Hopkins School of Public Health, USA Overview Know your epidemic

More information

The EACS Standard of Care initiative. The Standard of Care for HIV and Coinfections in Europe meeting in Rome: a reminder

The EACS Standard of Care initiative. The Standard of Care for HIV and Coinfections in Europe meeting in Rome: a reminder The EACS Standard of Care initiative. The Standard of Care for HIV and Coinfections in Europe meeting in Rome: a reminder Antonella d Arminio Monforte, University of Milan Cristina Mussini, University

More information

The Syndemics of HIV, Hepatitis, and Overdose

The Syndemics of HIV, Hepatitis, and Overdose The Syndemics of HIV, Hepatitis, and Overdose Sara Zeigler Associate Director for Policy Office of Policy, Planning and Partnerships (proposed) Centers for Disease Control and Prevention National Center

More information

HIV epidemic around the Baltic Sea

HIV epidemic around the Baltic Sea HIV epidemic around the Baltic Sea Pauli Leinikki National Public Health Institute Subtitles Statistics: what seems to have happened Dynamics: in what order Dissection: what actually happened Target friendly

More information

The WHO END-TB Strategy

The WHO END-TB Strategy ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who

More information

Signs of success latest national NESI data?

Signs of success latest national NESI data? Needle Exchange Surveillance Initiative Signs of success latest national NESI data? Alison Munro (University of the West of Scotland) Study partners Professor Avril Taylor Chief Investigator (UWS) Dr Alison

More information

COUNTRY TABLE. MONTENEGRO.

COUNTRY TABLE. MONTENEGRO. EPIDEMIOLOGICAL DATA Indicator Data Source of data/additional notes re data Year of estimate Population 620 029 National Census data 2011 Estimated number of people who inject drugs (PWID) 1282 (95%CI

More information

Strategies to Address HCV

Strategies to Address HCV Strategies to Address HCV HIV Programs & U.S. Viral Hepatitis Action Plan Corinna Dan, RN, M.P.H. Viral Hepatitis Policy Advisor Office of HIV/AIDS and Infectious Disease Policy September 10, 2015 1 The

More information

The evolution of the HIV/AIDS outbreak among IDUs in Romania

The evolution of the HIV/AIDS outbreak among IDUs in Romania The evolution of the HIV/AIDS outbreak among IDUs in Romania Romanian National Antidrug Agency Romanian National Focal Point on Drugs Andrei Botescu * Lisbon, 12 th October 2012 HIV outbreak among IDU

More information

Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers)

Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers) Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers) Joseph LARMARANGE - CEPED/IRD Symposium ANRS - AIDS 2012-23 July 2012 Epidemiological context» South America

More information

Towards universal access

Towards universal access Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress

More information

MSM AND HIV/AIDS IN AFRICA WITH FOCUS ON MALAWI

MSM AND HIV/AIDS IN AFRICA WITH FOCUS ON MALAWI Center for Public Health and Human Rights MSM AND HIV/AIDS IN AFRICA WITH FOCUS ON MALAWI Malawi College of Medicine: Eric Umar Vincent Jumbe CEDEP: Gift Trapence Dunker Kamba Rodney Chalera Johns Hopkins

More information

Bangladesh Country Advocacy Brief Injecting Drug Use and HIV

Bangladesh Country Advocacy Brief Injecting Drug Use and HIV United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS for Asia and the Pacific Bangladesh Country Advocacy Brief Injecting Drug Use and HIV Call to Action Use the benefit of time to avert

More information

Improving accessibility to antiretroviral drugs: A south-south collaboration

Improving accessibility to antiretroviral drugs: A south-south collaboration Improving accessibility to antiretroviral drugs: A south-south collaboration Jaideep A Gogtay MD Cipla Ltd Mumbai jgogtay@cipla.com Adults and children estimated to be living with HIV at the end of 2000

More information

Report of the 16 th. Core Group meeting Almaty, Kazakhstan May 26-28, 2010

Report of the 16 th. Core Group meeting Almaty, Kazakhstan May 26-28, 2010 Report of the 16 th Core Group meeting Almaty, Kazakhstan May 26-28, 2010 The 16 th meeting of the Core Group of the TB/HIV Working Group of the Stop TB Partnership was conducted in Almaty, Kazakstan from

More information